T1	intervention 64 73	letrozole
T2	control 77 84	placebo
T4	eligibility 671 712	post-menopausal BRCA1/2 mutation carriers
T5	total-participants 834 837	113
T6	total-participants 922 927	1,505
T7	total-participants 1228 1256	Five hundred and thirty-four
T3	outcome 1477 1508	Uptake of drug prevention trial
T8	outcome 1614 1636	potential side effects
T9	outcome 1638 1672	probability to receive the placebo
T10	outcome 1677 1714	lack of support from their physicians
T11	outcome 1967 1973	uptake
